Swedish Health Services Installs VolparaEnterprise Software to Enhance Mammography Image Quality

Breast Imaging Analytics Software Helps Breast Care Team Deliver Personalized Health with High-Quality Images

Volpara Health Technologies to Acquire MRS Systems, Inc.

Companies Committed to Deliver Technologies Enabling Personalized Breast Care

Journal of Breast Imaging Study Validates VolparaDensity in Tyrer-Cuzick Breast Cancer Risk Model

Wellington, NZ, May 20, 2019 – Research has demonstrated that the use of Volpara Solutions’ Volpara®Density™ software in combination with the Tyrer-Cuzick Breast Cancer Risk Evaluation Tool improves breast cancer...

Volpara Secures Medical Device Single Audit Program (MDSAP) 690110 Certification

MDSAP Certification Satisfies ISO and Regulatory Compliance Requirements for Japan, Australia, Canada, and the United States

Volpara Celebrates 10 Years of Striving to Save Families from Breast Cancer

Volpara boasts many accomplishments in its 10-year history. Some of the most notable include the following:

Volpara Solutions Expands Relationship with GE Healthcare

GE Healthcare is now a global distributor of Volpara®Density™ software

Volpara Solutions Showcases New Research and a New Version of VolparaLive! at ECR

Volpara Solutions’ Quantitative Breast Imaging Tools Support 11 Breast Screening Studies Presented at ECRVIENNA, February 26, 2019 – Volpara Solutions Ltd will launch a new version of the Volpara®Live!™ system...

Volpara Solutions Launches Next-Generation VolparaDensity Software to Support Hologic’s Curved Paddles

Recent FDA Clearance Enhances Breast Density Assessment Performance and Expands the Types of Information Provided to Clinicians 

Quantitative Analysis Improves Breast Screening: Research Highlights from RSNA

Volpara Solutions’ Quantitative Breast Imaging Tools Continue to Be Widely Used in Research

Volpara Showcases Latest VolparaEnterprise Software Tools at RSNA

Speaker Series includes Prof Jack Cuzick, DBI’s JoAnn Pushkin, Mammography Educators’ Amy Chatten, and Oxford University’s Prof Sir Mike Brady

1 2 3 4 5 8